Lysogene

is a France-based biopharmaceutical company that researches and develops gene therapies for the treatment of central nervous system diseases...
Read more
Lysogene Chairman & CEO: Karen Pignet-Aiach

Chairman & CEO

Karen Pignet-Aiach

CEO Approval Rating

90/100

Annual Revenue
$16.4M
Employees
22
Funding
$82.9M

Lysogene Competitors

1Renova Therapeutics
2Jaguar Gene Therapy
3Spark Therapeutics
4Regenxbio
5uniQure
6Sangamo
7Prevail Therapeutics
8Qrons
9AXON Neuroscience
10Dimension Therapeutics

Trending Companies